GENTERRA
Live / Applied — Fourth extension granted (statement of use) (as of 28 Jan 2026)
What this means for you
Not registered yet, but its 13 Jun 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98040563
- Mark type
- Stylized text
- Filed
- 13 Jun 2023
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Jayme M. Torelli
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology
Owner
- Vanda Pharmaceuticals Inc., Washington, DC, US
- Vanda Pharmaceuticals Inc., Washington, DC, US
Prosecution history
- 29 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2026 — SOU EXTENSION 4 GRANTED
- 28 Jan 2026 — SOU EXTENSION 4 FILED
- 28 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 28 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2025 — SOU EXTENSION 3 GRANTED
- 27 Jun 2025 — SOU EXTENSION 3 FILED
- 27 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jan 2025 — SOU EXTENSION 2 GRANTED
- 03 Jan 2025 — SOU EXTENSION 2 FILED
- 02 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 01 Aug 2024 — SOU EXTENSION 1 GRANTED
- 01 Aug 2024 — SOU EXTENSION 1 FILED